Categories: NEWS

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

“My Path with Sintetica”

Special Keynote Speaker: Nicola Caronzolo, Corporate CEO, Sintetica SA

When: 18 November 5.45 PM

Where: Executive Center, USI

Nicola Caronzolo, Corporate CEO of Sintetica SA, headquartered in Mendrisio, Switzerland.

SINTETICA SA.

Established in 1921 and headquartered in Mendrisio, Sintetica is a Swiss pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing.

Sintetica has developed a clear innovation strategy following patient needs and new sustainable pharma trends.

For more info, visit the website: https://sintetica.com/

Nicola Caronzolo.

I deeply love this company for which I have worked for 20 years with passion, energy and dedication. I love its nature, its history, the magical mix that we have been able to build, all together, between great professionalism in doing and deep respect in living.

After earning a Bachelor’s degree in Industrial Chemistry at the University of Milan, Nicola Caronzolo specialised in Polymer Science at the Giulio Natta School in Milan. A dual-national, Italian and Swiss, Nicola Caronzolo lives with his family in Lugano, Canton Ticino. After his studies, Mr. Caronzolo worked as an academic researcher at the University of Milan and afterwards for a company that manufactured polymeric support drugs. He joined Sintetica in 2002, when the company was beginning its progressive path of major expansion. He had an extensive career in the Industrial Affairs division and, after several years as Chief Operating Officer, he was appointed CEO of the company in February 2022. In his new role as CEO, Nicola Caronzolo intends to work to consolidate the major strategic directions of marketing Sintetica’s products in the most important global markets.
At the same time, he is committed to further strengthening the innovation sector, one of the hallmarks of this pharmaceutical company known for the quality of its products and its ability to innovate therapies by customising the answers to questions from professionals. What he finds fascinating is that such a growing company faces many challenges. Those challenges are determined by the company itself, and everyone works together to overcome them.

 

Book your place: emba@usi.ch

 

EmbaSt

Recent Posts

Empowering Entrepreneurs: How the USI EMBA Fuels Startup Growth and Leadership

In the dynamic landscape of modern business, entrepreneurs face unprecedented challenges and opportunities. The USI…

1 giorno ago

Negotiation: A Core Competency Fostered in the USI Executive MBA

The ability to negotiate effectively has evolved from a desirable skill to an essential competency…

1 giorno ago

EMBA 14 OPEN DAY 03.06

Join the USI EMBA Open Day on June 3rd 2025, at 6:15 PM. Explore the…

6 giorni ago

How an Executive MBA Enhances Strategic Decision-Making

The USI Executive MBA transforms professionals into leaders through analytical training, diverse perspectives, and real-world…

1 settimana ago

The USI Executive MBA Experience: peer learning and networking

At USI Executive MBA program, one of the most powerful educational forces lies in the…

2 settimane ago

The Global perspective of the USI Executive MBA

The USI Executive MBA transforms professionals into visionary global leaders through its international faculty, diverse…

2 settimane ago